Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009307 · ClinicalTrials.gov registry record
Study of Blood and Cheek Cell Samples From Patients With Glioma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,709
- Enrollment target
NCT01009307: Completed study, sponsored by University of California, San Francisco.
NCT01009307 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,709 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01009307 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,709 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at blood and cheek cell samples from patients with glioma.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,709 participants |
| Start Date | 2001-10 |
What the finished NCT01009307 record still lists
NCT01009307 is an observational study that tracks outcomes without assigning an intervention. Its 1,709 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01009307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01009307 about?
NCT01009307 is a clinical study titled "Study of Blood and Cheek Cell Samples From Patients With Glioma". RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is...
What is the current status of trial NCT01009307?
This trial is currently completed. The enrollment target is 1,709 participants. The study started on 2001-10.
What interventions are being tested in trial NCT01009307?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT01009307?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia